Targeting DNA Methylation with Small Molecules: What’s Next?
- 4 December 2014
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 58 (6) , 2569-2583
Abstract
DNA methylation is a mammalian epigenetic mark that is involved in defining where and when genes are expressed, both in normal cells and in the context of diseases. Like other epigenetic marks, it is reversible and can be modulated by chemical agents. Because it plays an important role in cancer by silencing certain genes, such as tumor suppressor genes, and by reactivating other regions, such as repeated elements, it is a promising therapeutic target. Two compounds are already approved to treat hematological cancers. Many efforts have been carried out to discover new molecules that are able to efficiently inhibit DNA methylation in cancer cells. We will briefly overview the foremost of these efforts by focusing on what we have learned to this point on non-nucleoside inhibitors and on what we consider to be the features of an ideal inhibitor.Keywords
Funding Information
- Fondation Innabiosanté
This publication has 138 references indexed in Scilit:
- Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor CellsCancer Cell, 2012
- Selective Inhibitors of Histone Methyltransferase DOT1L: Design, Synthesis, and Crystallographic StudiesJournal of the American Chemical Society, 2011
- Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluationBioorganic & Medicinal Chemistry, 2010
- DNA (Cytosine-C5) methyltransferase inhibition by oligodeoxyribonucleotides containing 2-(1H)-pyrimidinone (zebularine aglycon) at the enzymatic target siteBiochemical Pharmacology, 2009
- CpG islands – ‘A rough guide’FEBS Letters, 2009
- Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabineInternational Journal of Cancer, 2008
- Perceptions of epigeneticsNature, 2007
- Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genomeNature Genetics, 2007
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002